Executive leadership team – Aymeric Le Chatelier - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Media  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Media Contacts

    • Our 2023 Integrated Annual Report is live!

       Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category
    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
    • Lay Summaries
  • Sustainabilityarrow down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
Back

Post navigation

Previous
Next

Executive leadership team – Aymeric Le Chatelier

© Ipsen Pharma. All rights reserved

Usage policy

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Executive leadership team – Aymeric Le Chatelier

- 17 May 2023 - 1 mins read

© Ipsen Pharma. All rights reserved

Usage policy

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Post navigation

Previous
Next

Related Library

Executive leadership team – Laura Réveillon
14 May 2025 1 mins read

Executive leadership team – Laura Réveillon
Executive leadership team – Olivia Brown
01 April 2025 1 mins read

Executive leadership team – Olivia Brown
Executive leadership team – Josep Catllà 
20 August 2024 1 mins read

Executive leadership team – Josep Catllà 
Executive leadership team – Keira Driansky
13 May 2024 1 mins read

Executive leadership team – Keira Driansky
Executive leadership team – Christelle Huguet
25 September 2023 1 mins read

Executive leadership team – Christelle Huguet
Executive leadership team – Sandra Silvestri
17 May 2023 1 mins read

Executive leadership team – Sandra Silvestri
Executive leadership team – Mari Scheiffele
17 May 2023 1 mins read

Executive leadership team – Mari Scheiffele
Executive leadership team – Aidan Murphy
17 May 2023 1 mins read

Executive leadership team – Aidan Murphy
Executive leadership team – Régis Mulot
17 May 2023 1 mins read

Executive leadership team – Régis Mulot
Executive leadership team – Philippe Lopes Fernandes
17 May 2023 1 mins read

Executive leadership team – Philippe Lopes Fernandes

IPN price

€101.90

 €0.70 (0.69%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Sustainability
  • Patients
  • Stories
  • Annual Report
  • Contact us
Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue